JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic
NVIDIA starts 2025 by announcing a trio of partnerships and a research collaboration to boost healthcare sector presence.
Eli Lilly targets Scorpion Therapeutics to expand reach in oncology
Pfizer pitches pipeline priorities in oncology and obesity at JP Morgan 2025
JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance
Alzheimer’s total prevalent cases to reach 22.51 million in 8MM in 2033
Daiichi Sankyo buys solid tumour ADC from Glycotope for $132.5m
Analysis
View More
Themes
View MoreFDA CDER director Patrizia Cavazzoni announces resignation
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Artificial intelligence and atopic dermatitis: A new era for disease management?
Eli Lilly’s UK life sciences investment ‘a pivotal moment’, says analyst
Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19
Novo Nordisk invests $1.2bn in new Denmark facility